chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle aches, joint pain, lymph under arm tender, restless, jiggy legs (?) , inability to sleep Fever started at 3am 04/19/2021, persisted thru day despite Tylenol dosage 1000mg  Lethargic, weakness, headache, low grade constant fever, some bouts of chills . Mizzy guts! Please fix this vaccine, can't do that again. Cancelled all work calls on the 19th, stayed in bed. Relief by next morning 20 April
Sudden on set. Intense headache that lasted until midnight (6 hrs). Light sensitivity. Dizziness, Heart racing very nauseous. Eye pain. Shakiness. Those symptoms lasted 1.5 hours. Acetaminophen given. When she woke up in the morning o 2/7/19 - all symptoms were gone.
Irregular menstrual bleeding (duration 2.5+ months, normal Hysteroscopy and ultrasound). Currently taking oral contraceptives to try to correct.
Swelling 8 days post injections in left cheek . Filler placed 8 months prior
The moderna vaccine had been out of the freezer for more than 30 days at the time of administration.  Date of receipt was 09/20/2022, date of  vaccination was 11/14/2022
Incorrect product storage; This spontaneous report was received from a registered nurse who referred to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, as well as drug reactions or allergies were not provided.  Since 28-JUL-2020, the temperature excursion was intermittent and on an unknown, the patient was inadvertently administered with  an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter (lot # S032357 had been verified to be a valid number; expiration date 14-OCT-2021) (T002843 had been verified to be a valid number; expiration date 23-JAN-2022); and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHa) (dose not reported) (lot number T009929 and S031882  have been verified to be valid lot numbers; expiration dates: 16-SEP-2021 and 07-APR-2021, respectively); both vaccines for prophylaxis (strengths, frequencies, routes of administration, and anatomical locations were not reported). The  temperature  excursion was at -14 degrees Celsius (C) to -10 degrees C (max -9.5 degree C) , for a time frame of 38 hours and 30 minutes, and no had previous temperature excursion. It was reported that the call was due to data logger.
stiffness in joints, progressing to knee & wrist pain, followed by pleural effusion & finally dx & tx for rheumatoid arthritis;sx began p/2nd shot & have persisted for more than a year;60 day follow-up dated 9/29/00 states the pt has been diagnosed with fibromyalgia. Annual follow-up dated 1/22/01 provided no additional data.
88 YO AM with Afib, CHF, CAD, and pulmonary HTN received SHINGRIX vaccine on 7/31/2018. The patient reported muscle ache and nausea for nearly a week after the immunization during a follow-up visit on 9/5/2018. Symptoms resolved and no other action was taken. The provider notes that the patient will likely refuse the second dose of SHINGRIX due to the reaction. *Note-Information provided above is about the extent documentation provided within the EHR.
Adverse events: unstable,  too dizzy to walk, through-up, double vision. Treatment: wait for the symptoms to pass.. The symptoms have lessened but are still with me.
Starting the day after vaccine, experienced pain 4 inches below site which steadily increased. On 01/7/2021 at 6 am noticed redness and warmth. Rx Bactrim on 01/7/2021 and have taken 2 doses and redness, warmth and pain have increased. Also have pain up right shoulder and right sided headache. Slight nausea, afebrile. PMD wanted me to report adverse reaction.
inconsolable crying for 12 hrs starting 2-3 hrs p/vax; t101-DTP site red & swollen APAP, Pediaprofen, DPH;
L upper arm started itching badly 1/5/21 later in the afternoon.  I finally looked at it in the evening.  The skin was red around the injection site, at least 3x5".  At the margin there were a number of small hives and the entire area was hot and indurated.  It was not painful, just itchy.  The next day the hives were gone but the area was larger, and still red, hot and indurated.  It continued that way and grew in size that day and the next.  Itching improved and by Friday 1/8 the redness was gone (almost completely encircled my arm at one point).  I still have occasional itching.  One of the physicians I work with said it was a delayed hypersensitivity reaction and that I should get the 2nd shot in the R arm and pre-medicate.
It started last on July 13th, 2022 with what felt like the beginning of a sinus infection. Pressure in my sinuses and post nasal drip. On the following day, I developed a cough. Soon after, I took an at home COVID-19 test and it was positive. Then, we went to an urgent care facility and saw a physician's assistant there. He prescribed LAGEVRIO. I have been taking this 5 day regimen and am feeling about the same. I wouldn't say better and I wouldn't say worse.
Bells Palsy - Left sided; This is a spontaneous report from a contactable physician. A 76-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL9263) intramuscular in left arm on 23Jan2021 at single dose for COVID-19 immunization. Medical history included DMII (Type II diabetes mellitus), Parkinson's disease, and CAD (coronary artery disease). Concomitant medications were not reported. The patient previously took metformin and experienced allergy. Prior to vaccination, patient was not diagnosed with COVID-19; and since vaccination, patient has not been tested. Facility where the most recent COVID-19 vaccine was administered: Other (Public Health Department). On 24Jan2021, the patient experienced Bells Palsy - Left sided. The event required physician office visit (Doctor or other healthcare professional office/clinic visit). No treatment was received for the event. Outcome of the event was unknown.
chills and rigor; fever/febrile; headache; nausea; whole body muscle aches; This is a spontaneous report from a non-contactable nurse (patient). A 30-year-old adult female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: Ej1686), via an unspecified route of administration on 10Jan2021 10:30 AM at single dose on the left arm for COVID-19 immunisation. The patient is not pregnant at the of report. COVID-19 vaccine was administered in the hospital.  Medical history included migraine, Polycystic ovarian syndrome (Pcos), seasonal allergies, penicillin and sulfa antibiotics allergies. Concomitant medications (Other medications in two weeks) included levothyroxine sodium (SYNTHROID), spironolactone, montelukast sodium (SINGULAIR), loratadine (CLARITIN [LORATADINE]) and calcium levomefolate (DEPLIN). The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: Ej1685) on 21Dec2020 03:15 PM on the left arm. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior vaccination. The patient reported that on 11Jan2021 12:00 AM, 14 hours post receiving the second dose, she had chills and rigor and ended up with a fever. Patient took Tylenol, fever broke and 4 hours later again had chills and rigor febrile again and took ibuprofen. The patient also had headache, nausea, and whole body muscle aches. The events were assessed as non-serious. Outcome of the events was recovering. The patient has not been tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
ACUTE RESPIRATORY FAILURE 12/23/2022 -- RECURRENCE OF SAME SYMPTOMS
then itch was mild for 1 hour/Started itching all over the worst was behind; itching all over the worst was behind my eyes deep in sockets; Sharp pain both arms 1 min.; left arm was swollen; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 30Apr2021 at 11:15 (at the age of 40-years-old) as 1st dose, single for COVID-19 immunisation. Medical history was reported as yes but not specified. The patient's concomitant medications were not reported. On 30Apr2021 at 11:15, the patient experienced sharp pain both arms for 1 minute then itch was mild for 1 hour. Started itching all over the worst was behind her eyes deep in sockets that lasted 2 days, had to take diphenhydramine (BENADRYL). Left arm was swollen that night and lasted 2 days. On day 3, she was still itching but not as bad. Therapeutic measures were taken as a result of all events. The outcome of the events was recovering.         No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
had an earlier hosp admission with dx of DKA, ARF, NSTEMI and was later discharged to SNF; while at SNF pt tested positive for COVID; pt now presents to ED with increasing SOB, fever; increasing O2 demands over hosp stay; pt became confused and agitated; pt's condition worsened and he was eventually made comfort measures; pt died in the hospital
Immediate vasovagal reaction to the vaccine with bradycardia to 30, pale, quickly improved without additional intervention. History of fainting reaction to any shots and blood draw. Family at his side. The patient is not driving today.
-By evening of 1/6/21 , 1st dose vaccine, approx. 6-7 hours post:  beginning of muscle aches, chills, fatigue.  -By next morning, approx.  17 hours post 1st vaccine - 46 hours post 1st vaccination: extreme muscle aches and body pain sensitivity throughout skin/nerve endings - painful to touch skin or even turn over in bed.  strong chills. Fever up to 102.5 or 102.7 with fever reducing OTC meds. Areas of existing chronic pain in both arms (tennis elbow) and neck had significantly more pain - burning pain and tenderness that prevented sleep.  -Approx. 46-47 hours post 1st vaccination fever broke and symptoms started subsiding significantly. -Approx.  55 hours post 1 vaccination, most symptoms gone except light aches and fatigue.    extra sensitivity in chronic pain areas of arms and neck persisted for at least 2 week post 1st vaccination.   -2nd vaccination on 2/2/2021 - same as above - chills  and skin sensitivity slightly reduced.
Red mark, size of a quarter, on her arm; for over a year; Itchy; drives her insane; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  An adult female patient received BNT162b2 (BNT162B2), on 03Jan2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ERYTHEMA (non-serious), outcome "not recovered", described as "Red mark, size of a quarter, on her arm; for over a year"; PRURITUS (non-serious), outcome "not recovered", described as "Itchy; drives her insane".  Additional information: Received her first Pfizer Covid 19 vaccine on 03Jan2021. Caller states since then, she has had a red mark, size of a quarter, on her arm later states, as itchy. Caller states it is now 2022 and it is still on her arm, it is itchy, and drives her insane. Specifically still itchy and red for over a year?  The information on the batch/lot number for (BNT162B2), has been requested and will be submitted if and when received.
Given the Polio 0.1ml on the left forearm intrademally.  Patient was called to be notify after speaking with Provider and notify. Patient agree to come back into the office. Stated she was feeling fine and advise she could still receive the PPD as sch. Patient agree had PPD done on right forearm No complications to report
It started 5-6 hours after the shot with headache and dizziness . In the evening I had a fever of 37,6°C and because I was scared it will be higher I took pills for fever. On the second day I had muscular pain and my fingers were swollen in the morning. Also I had lower back pain, runny nose and I was nauseous . On the 3rd day I was feeling dizzy, nauseous, couldn't concentrate and an intense headache. Pills weren't helping at all
Loss of taste Loss of appetite  No balance  Chills Headache  Sore arms Sore legs Brain fog  Stomach upset  Loss of weight
pt recv vax 3APR96 & 4APR96 had itching @ inj site w/tenderness myalgias,arthralgias,t101,also devel intermittent diffuse pruritus;inj site became swollen & painful;15APR96 PE,t98.8,7 1/2 x 6cm erythematous,tender,indurated,warm inj
Patient become dizzy and overall not feeling well, patient was placed supine and hooked up to a pulse oximetry.  Oxygen saturations were WNL but heart rate tachy, was placed on telemetry which showed tachycardia 160-180, blood pressure elevated, patient was anxious and to note was also nervous/anxious about receiving vaccination prior to injection. Patient was then transferred to the ER to be evaluated by MD.  At that time EKG completed with NSR 94, BP 133/85, 100 % oxygen on room air, respirations - 20.  Dizziness and tachycardia subsided within 20 minutes without intervention, patient continued to be anxious regarding event.
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. On 14-JUN-2017, the patient was vaccinated with the first dose of improperly stored VARIVAX, lot#656078/0169U. On 15-JUL-2008, the patient was vaccinated with second dose of improperly stored VARIVAX lot#:661445/0525X. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient had localized swelling and pain a few days after injection.  Received treatment from the physician.
nausea; extreme fatigue/tiredness; left arm very sore and achy, it became very stiff; left arm very sore and achy, it became very stiff; body aches increased; body aches increased; headaches on and off; chills; night sweats really bad for two nights; light fever; nose running; light cough; This is a spontaneous report from a contactable consumer who reported for herself. A 58 (units unknown) non-pregnant adult female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot #: E10140) via an unspecified route of administration on 14Jan2021 as a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure (High blood pressure-take medication, heart medicine also) from an unspecified date and unspecified if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unspecified date and unspecified if ongoing. It was reported that the patient had no known allergies. Concomitant medications were not reported. It was reported that the patient had not taken other medications in two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Jan2021 at 17:30 (reported as "on Friday after the first dose") the patient experienced nausea, extreme fatigue, left arm very sore and achy, it became very stiff, body aches increased, headaches on and off, chills and night sweats really bad for two nights, tiredness, light fever, nose running and light cough. The clinical outcome of the events nausea, extreme fatigue, left arm very sore and achy, it became very stiff, body aches increased, headaches on and off, chills and night sweats really bad for two nights, tiredness, light fever, nose running and light cough were all recovering/resolving. It was reported that no treatment was received for the adverse events. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
red blotchy on upper arm; COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red blotchy on upper arm) and HYPERSENSITIVITY (COVID arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH MACULAR (red blotchy on upper arm) and HYPERSENSITIVITY (COVID arm). At the time of the report, RASH MACULAR (red blotchy on upper arm) and HYPERSENSITIVITY (COVID arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sudden onset of shortness of breath. Hypoxic on room air. Respiratory distress, rales, tachypnea,tachycardia
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 21Sep2023 as dose 1, single (Batch/Lot number: unknown) at the age of 38 years for covid-19 immunisation. The patient's relevant medical history included: "Type 1 Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "recovered" (08Nov2023) and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Positive, notes: Treatment of COVID-19; (08Nov2023) negative. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Paxlovid given from 01Nov2023 to 05Nov2023. Tested negative on 08Nov2023. There were no symptoms  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300367335 same patient, different drug, different event;
Despite pt having a shoulder injection site rxn 1 day after injection, she didn't report time until 10-20-17. Redness extended 1/2 way around arm, elbow, itchy, painful, hot, hard to touch. Still red in areas. Advised pt to take BENADRYL, ice, hydrocortisone but she didn't.
Tingling, numbness and itching sensation in left arm and hand  and left leg and foot
Initial report received from healthcare professional on 21 October 2014. A 74-year-old female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of FLUZONE HD (Batch number U5022BA, expiry date 29 Apr 2015 and dose number was not reported) in to the deltoid left on 20 October 2014. The patient had experienced an area of redness 2 inches below the injection site on 21 October 2014. Lab investigations were not reported and corrective treatments included ice therapy. The patient illness at the time of vaccination, pre-existing diagnosed allergies and birth defects were not reported. The outcome of the event was unknown at the time of this report. List of documents held by sender: none.
Fatigue all day, chills12:00 pm - 7:00 pm,  headache and body aches, fever of 101.5 12-7
shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to an elderly male patient (pt) who at the time of vaccination was approximately 72 years old. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On or about 06-OCT-2016, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) at a pharmacy for the long-term prevention of shingles and zoster-related conditions. As a result of the said administration, the pt was caused to suffer shingles, including any and all of its sequelae (also reported as subsequently (date not provided), the pt was treated by a healthcare provider for shingles, resulting from the pt's use of zoster vaccine live (ZOSTAVAX)). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) manufacturing defect, the pt suffered severe and permanent physical injuries, including but not limited to shingles, as well as other severe and permanent health consequences (also reported as had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages). The pt had endured substantial pain and suffering. He had incurred significant expenses for medical care and treatment, and would continue to incur such expenses in the future. The pt had lost earnings and had suffered a loss of earning capacity. The pt had suffered and would continue to suffer economic loss, and had otherwise been physically, emotionally and economically injured. The pt's injuries and damages were permanent and would continue into the future. The outcome of the event was considered to be not recovered. The reported considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).  The event of shingles was considered to be disabling.
On 03/14/2021, I developed a rash or urticaria. I saw the doctor on 03/15/2021- I took a course of Prednisone.  They also did a biopsy. The report was inconclusive.  It was either an allergic reaction , or medicine reaction or a bite and was exacerbated by the vaccine. I have had hives or rash previously,  but this reaction was much worse than I have ever had before  or since the vaccine.
No adverse event; first dose of Moderna Covid vaccine on 8Mar2021, and then received a dose of Pfizer BioNTech Covid 19 vaccine on 14Jul2021; interchange of vaccine products; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (No adverse event), COVID-19 IMMUNISATION (first dose of Moderna Covid vaccine on 8Mar2021, and then received a dose of Pfizer BioNTech Covid 19 vaccine on 14Jul2021) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2021, the patient received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 14-Jul-2021, the patient experienced COVID-19 IMMUNISATION (first dose of Moderna Covid vaccine on 8Mar2021, and then received a dose of Pfizer BioNTech Covid 19 vaccine on 14Jul2021) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, NO ADVERSE EVENT (No adverse event), COVID-19 IMMUNISATION (first dose of Moderna Covid vaccine on 8Mar2021, and then received a dose of Pfizer BioNTech Covid 19 vaccine on 14Jul2021) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for COVID-19 IMMUNISATION (first dose of Moderna Covid vaccine on 8Mar2021, and then received a dose of Pfizer BioNTech Covid 19 vaccine on 14Jul2021) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products).    Concomitant products were not provided. Treatment medication were not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pain, heaviness, swelling, redness, itching, extreme induration and tenderness at injection site; severe headache.
Within a few hours, swelling and redness on right deltoid. No systemic symptoms, no throat or respiratory symptoms SC edema noted with tenderness on exam. Treated with Medrol dose pack and ice.